S.No. |
Title |
Source Title |
Authors |
DOI |
Citing Works Count |
1 |
Editorial (Thematic Issue: New Behaviors, New Drugs: The Modern Landscape of Addiction)
|
Current Pharmaceutical Design
|
Laurent Karila
|
10.2174/13816128113199990627
|
0
|
2 |
Protease-Activated Receptors as Therapeutic Targets in Visceral Pain
|
Current Neuropharmacology
|
Nicolas Cenac
|
10.2174/1570159x113119990039
|
21
|
3 |
Pleiotropic Beneficial Effects of Epigallocatechin Gallate, Quercetin and Delphinidin on Cardiovascular Diseases Associated with Endothelial Dysfunction
|
Cardiovascular & Hematological Agents In Medicinal Chemistry
|
Ousama Dayoub; Ramaroson Andriantsitohaina; Nicolas Clere
|
10.2174/1871525712666140309233048
|
16
|
4 |
Indocyanine green: photosensitizer or chromophore? Still a debate
|
Current Medicinal Chemistry
|
Camille Giraudeau; Albert Moussaron; Aurélie Stallivieri; Serge Mordon; Céline Frochot
|
10.2174/0929867321666131218095802
|
43
|
5 |
Human Imprinting Anomalies in Fetal and Childhood Growth Disorders: Clinical Implications and Molecular Mechanisms
|
Current Pharmaceutical Design
|
Salah Azzi; Frédéric Brioude; Yves Le Bouc; Irène Netchine
|
10.2174/13816128113199990525
|
8
|
6 |
Effectiveness of a Standardized and Specific Follow-Up in Memory Centers in Patients with Alzheimer's Disease.
|
Current Alzheimer Research
|
Laure Rouch; Philippe Cestac; Charlène Cool; Catherine Helmer; Jean-François Dartigues; Claudine Berr; Olivier Rouaud; Bruno Vellas; Sandrine Andrieu
|
|
1
|
7 |
Hypoxic culture conditions for Mesenchymal Stromal/Stem Cells from Wharton's jelly: a critical parameter to consider in a therapeutic context.
|
Current Stem Cell Research & Therapy
|
Loïc Reppel; Talar Margossian; Layale Yaghi; Philippe Moreau; Nathalie Mercier; Léonore Leger; Sébastien Hupont; Jean-François Stoltz; Danièle Bensoussan; Céline Huselstein
|
10.2174/1574888x09666140213204850
|
21
|
8 |
Reducing GABAergic inhibition restores cognitive functions in a mouse model of Down syndrome.
|
CNS & Neurological Disorders Drug Targets
|
Marie-Claude Potier; Jérôme Braudeau; Luce Dauphinot; Benoît Delatour
|
10.2174/18715273113126660185
|
19
|
9 |
The "Methyl-CpG Binding Domain protein 2" plays a repressive role in relation to the promoter CpG content in the normal human cell line MRC5.
|
Current Pharmaceutical Design
|
Laury Perriaud; Joël Lachuer; Robert Dante
|
10.2174/13816128113199990537
|
1
|
10 |
Specificities of the diabetic population in French Guiana: The health barometer survey.
|
Current Diabetes Reviews
|
Nadia Sabbah; Mickael Massicard; Nacher Mathieu
|
10.2174/1573399817666210129103506
|
0
|
11 |
Association Between Oxidative Stress and Altered Cholesterol Metabolism in Alzheimer's Disease Patients.
|
Current Alzheimer Research
|
Amira Zarrouk; Souha Hammouda; Imen Ghzaiel; Sonia Hammami; Wided Khamlaoui; Samia Hadj Ahmed; Gérard Lizard; Mohamed Hammami
|
10.2174/1567205017666201203123046
|
0
|
12 |
New Paradigms to Help Decisions in Treatment Choice: Head to Head Trial of Biological Therapies in Inflammatory Bowel Diseases.
|
Current Drug Targets
|
Laura Loy; Gionata Fiorino; Giulia Roda; Mariangela Allocca; Federica Furfaro; Alessandra Zilli; Daniela Gilardi; Simona Radice; Laurent Peyrin-Biroulet; Silvio Danese
|
10.2174/1389450121666201211162527
|
0
|
13 |
Application of Ultrasound Elastography for Assessing Intestinal Fibrosis in Inflammatory Bowel Disease: Fiction or Reality?
|
Current Drug Targets
|
Roberto Gabbiadini; Eirini Zacharopoulou; Federica Furfaro; Vincenzo Craviotto; Alessandra Zilli; Daniela Gilardi; Giulia Roda; Laura Loy; Gionata Fiorino; Laurent Peyrin-Biroulet; Silvio Danese; Mariangela Allocca
|
|
0
|
14 |
Lysine Methyltransferases Signaling: Histones are Just the Tip of the Iceberg
|
Current Protein & Peptide Science
|
Valentina Lukinović; Alexandre G. Casanova; Gaël S. Roth; Florent Chuffart; Nicolas Reynoird
|
10.2174/1871527319666200102101608
|
0
|
15 |
Human Exfoliated Deciduous Teeth Stem Cells: Features and Therapeutic Effects on Neurogenerative and Hepatobiliary-Pancreatic Diseases.
|
Current Stem Cell Research & Therapy
|
Nurul Wahidah Abdul Wahab; Rhanye Mac Guad; Vetriselvan Subramaniyan; Ismail M. Fareez; Ker Woon Choy; Srinivasa Reddy Bonam; Chandrasekaran Selvaraju; Maw Shin Sim; Subash C. B. Gopinath; Yuan Seng Wu
|
10.2174/1574888x15999200918105623
|
0
|
16 |
Inhibition of miR-223 Expression Using a Sponge Strategy Decreases Restenosis in Rat Injured Carotids.
|
Current Vascular Pharmacology
|
Eléonore M'Baya-Moutoula; Alexandre Marchand; Isabelle Six; Noura Bahrar; Tanja Ćelić; Nathalie Mougenot; Pierre Maitrias; Ziad A. Massy; Anne-Marie Lompré; Laurent Metzinger; Valérie Metzinger-Le Meuth
|
10.2174/1570161117666190705141152
|
6
|
17 |
Insights into Biophysical Methods to Study Interactions Between HIV-1 Reverse Transcriptase and Non-nucleoside Reverse Transcriptase Inhibitors
|
Letters In Drug Design & Discovery
|
Julien Dumond; Jean-Marcel Julien Tronchet; Serge Kirkiacharian; Michel Seman; Michèle Reboud-Ravaux
|
10.2174/1570180816666190723121845
|
0
|
18 |
The Experimentally Obtained Functional Impact Assessments of 5' Splice Site GT'GC Variants Differ Markedly from Those Predicted.
|
Current Genomics
|
Jian-Min Chen; Jin-Huan Lin; Emmanuelle Masson; Zhuan Liao; Claude Férec; David Neil Cooper; Matthew Hayden
|
10.2174/1389202921666200210141701
|
3
|
19 |
Resistant Hypertension: Novel Insights.
|
Current Hypertension Reviews
|
Guillaume Lamirault; Mathieu Artifoni; Mélanie Daniel; Nicolas Barber-Chamoux
|
10.2174/1573402115666191011111402
|
1
|
20 |
Common Pathological Mechanisms and Risk Factors for Alzheimer's Disease and Type-2 Diabetes: Focus on Inflammation.
|
Current Alzheimer Research
|
Emmanuel Moyse; Mohamed Haddad; Camelia Benlabiod; Charles Ramassamy; Slavica Krantic
|
10.2174/1567205016666191106094356
|
3
|
21 |
New Copper Compounds with Antiplatelet Aggregation Activity.
|
Medicinal Chemistry (Shariqah (United Arab Emirates))
|
Mirthala Flores-García; Juan M. Fernández-G; Cristina Busqueta-Griera; Elizabeth Gómez; Simón Hernández-Ortega; Jean Christian Daniel Lamothe-Flores; Virginia Gómez-Vidales; Ana María Mejía-Dom&iacut
|
10.2174/1573406415666190222123207
|
0
|
22 |
Impact of Collateral Status on Neuroprotective Effect of Cyclosporine A in Acute Ischemic Stroke.
|
Current Neurovascular Research
|
Norbert Nighoghossian; Lucie Cornut; Camille Amaz; Omer Eker; Nathan Mewton; Roxana Ameli; Lise Prune Berner; T.-H. Cho; Michel Ovize; Yves Berthezène
|
10.2174/1567202616666190618094014
|
0
|
23 |
Anti-adhesion Molecules in IBD: Does Gut Selectivity Really Make the Difference?
|
Current Pharmaceutical Design
|
Ferdinando D'Amico; Giulia Roda; Laurent Peyrin-Biroulet; Silvio Danese
|
10.2174/1381612825666190307165703
|
2
|
24 |
Anti-fibrotic Drugs for Crohn’s Disease: Ready for Prime Time?
|
Current Pharmaceutical Design
|
Marjorie Argollo; Daniela Gilardi; Giulia Roda; Gionata Fiorino; Laurent Peyrin-Biroulet; Silvio Danese
|
10.2174/1381612825666190308100844
|
2
|
25 |
Biosimilars of Adalimumab in Inflammatory Bowel Disease: Are we Ready for that?
|
Current Pharmaceutical Design
|
Marjorie Argollo; Gionata Fiorino; Daniela Gilardi; Federica Furfaro; Giulia Roda; Laura Loy; Mariangela Allocca; Laurent Peyrin-Biroulet; Silvio Danese
|
10.2174/1381612825666190312113610
|
5
|
26 |
Interleukin-23 Blockers: Born to be First-line Biologic Agents in Inflammatory Bowel Disease?
|
Current Pharmaceutical Design
|
Marjorie Argollo; Mariangela Allocca; Federica Furfaro; Laurent Peyrin-Biroulet; Silvio Danese
|
10.2174/1381612825666190313140811
|
4
|
27 |
Bacterial Protein Mimetic of Peptide Hormone as a New Class of Protein- based Drugs
|
Current Medicinal Chemistry
|
Sergueï O. Fetissov; Romain Legrand; Nicolas Lucas
|
10.2174/0929867324666171005110620
|
9
|
28 |
Dosimetry and Toxicity Studies of the Novel Sulfonamide Derivative of Sulforhodamine 101([18F]SRF101) at a Preclinical Level.
|
Current Radiopharmaceuticals
|
Ingrid Kreimerman; Erick Mora-Ramirez; Laura Reyes; Manuel Bardiès; Eduardo Savio; Henry Engler
|
10.2174/1874471011666180830145304
|
0
|
29 |
Neuroprotection with the Endozepine Octadecaneuropeptide, ODN.
|
Current Pharmaceutical Design
|
Olfa Masmoudi-Kouki; Yosra Hamdi; Ikram Ghouili; Seyma Bahdoudi; Hadhemi Kaddour; Jérôme Leprince; Hélène Castel; Hubert Vaudry; Mohamed Amri; David Vaudry; Marie-Christine Tonon
|
10.2174/1381612824666181112111746
|
5
|
30 |
Seven Novel and Three Known Mutations in FOXL2 in 10 Chinese Families with Blepharophimosis Syndrome.
|
Current Molecular Medicine
|
B Lin; Binghui Zeng; J Zhao; Tingting Xu; Ye Wang; Bin Hu; Fucheng Li; Qiang Zhao; Ruihong Liu; Jinsong Liu; Jian-Min Chen; D Huang
|
10.2174/1566524018666180907162619
|
0
|
31 |
Relevance of Follow-Up in Patients with Core Clinical Criteria for Alzheimer Disease and Normal CSF Biomarkers.
|
Current Alzheimer Research
|
Olivier Vercruysse; Claire Paquet; Audrey Gabelle; Xavier Delbeuck; Frédéric Blanc; David Wallon; Julien Dumurgier; Eloi Magnin; Olivier Martinaud; Barbara Jung; Olivier Bousiges; Sylvain Lehmann; Constance Delaby; Muriel Quillard-Murain; Ka
|
10.2174/1567205015666180110113238
|
3
|
32 |
Biologic therapies in ulcerative colitis: primi inter pares?
|
Current Drug Targets
|
Mariangela Allocca; Gionata Fiorino; Daniela Gilardi; Paoletta Preatoni; Alfredo Papa; Laurent Peyrin-Biroulet; Silvio Danese
|
10.2174/1389450117666160527142719
|
1
|
33 |
Synthesis and Antimalarial Activity of New Enantiopure Aminoalcoholpyrrolo[ 1,2-a]quinoxalines.
|
Medicinal Chemistry (Shariqah (United Arab Emirates))
|
Alexia Jonet; Jean Guillon; Catherine Mullié; Anita Cohen; Guillaume Bentzinger; Jeremy Schneider; Nicolas Taudon; Sébastien Hutter; Nadine Azas; Stéphane Moreau; Solène Savrimoutou; Patrice Agnamey; Alexandra Dassonville-Klimp
|
10.2174/1573406413666170726123938
|
7
|
34 |
Immunotherapy in Non-Small Cell Lung Cancer: Biological Principles and Future Opportunities.
|
Current Molecular Medicine
|
Marius Ilie; Jonathan Benzaquen; Véronique Hofman; Sandra Lassalle; Nathalie Yazbeck; Sylvie Leroy; Simon Heeke; Coraline Bence; Baharia Mograbi; Nicolas Glaichenhaus; C.-H. Marquette; Paul Hofman
|
10.2174/1566524018666180222114038
|
11
|
35 |
The Role of Cannabinoid Receptors in Renal Diseases.
|
Current Medicinal Chemistry
|
Hélène François; Lola Lecru
|
10.2174/0929867324666170911170020
|
9
|
36 |
Lipid Biomarkers in Alzheimer's Disease
|
Current Alzheimer Research
|
Amira Zarrouk; Meryam Debbabi; Maryem Bezine; El Mostafa Karym; Asmaa Badreddine; Olivier Rouaud; Thibault Moreau; Mustapha Cherkaoui-Malki; Mohamed El Ayeb; Boubker Nasser; Mohamed Hammami; Gérard Lizard
|
10.2174/1567205014666170505101426
|
52
|
37 |
Experimental Treatment Options in Absence Epilepsy.
|
Current Pharmaceutical Design
|
Gilles van Luijtelaar; Mehrnoush Zobeiri; Annika Lüttjohann; Antoine Depaulis
|
10.2174/1381612823666171017170226
|
5
|
38 |
Impact of Cone Beam Computed Tomography Dose in Pre-Surgical Implant Analysis
|
The Open Dentistry Journal
|
Nabil El Sahili; Ibrahim Nasseh; Antoine Berberi; Sandra David-Tchouda; Sophie Thoret; Thomas Fortin
|
10.2174/1874210601812010094
|
1
|
39 |
Early Vascular Ageing (EVA): Definitions and Clinical Applicability
|
Current Hypertension Reviews
|
Pedro Cunha; Pierre Boutouyrie; Peter M. Nilsson; Stéphane Laurent
|
10.2174/1573402113666170413094319
|
30
|
40 |
Convexity Subarachnoid Hemorrhage, Pseudomonas Aeruginosa (PA) Infective Endocarditis and Left Atrial Appendage Occluder (LAAO) Device Infection. A Case Report.
|
The Open Neuroimaging Journal
|
Monique Boukobza; Ibtissem Smaali; Xavier Duval; Jean-Pierre Laissy
|
10.2174/1874440001711010026
|
2
|
41 |
HDL-Targeting Therapeutics: Past, Present and Future.
|
Current Pharmaceutical Design
|
Emile Zakiev; Ma Feng; Vasily N. Sukhorukov; Anatol Kontush
|
10.2174/1381612822666161027153140
|
7
|
42 |
Use of Primary Macrophages for Searching Novel Immunocorrectors
|
Current Pharmaceutical Design
|
Nikita G. Nikiforov; Natalia V. Elizova; Michael Bukrinsky; Larisa Dubrovsky; Vsevolod J. Makeev; Yoshiyuki Wakabayashi; Poching Liu; Kathy K. Foxx; Howard S. Kruth; Xueting Jin; Emile Zakiev; Alexander N. Orekhov
|
10.2174/1381612823666170125110128
|
1
|
43 |
Melatonin: Pharmacology, Functions and Therapeutic Benefits.
|
Current Neuropharmacology
|
Sylvie Tordjman; Sylvie Chokron; Richard Delorme; Annaëlle Charrier; Eric Bellissant; Nemat Jaafari; Claire Fougerou
|
10.2174/1570159x14666161228122115
|
157
|
44 |
In vitro Vasorelaxant Effect of Artemisia herba alba Asso. in Spontaneously Hypertensive Rats
|
Cardiovascular & Hematological Agents In Medicinal Chemistry
|
Zeggwagh Naoufel; Morad Hebi; Mohammed Ajebli; J. Michel; Mohamed Eddouks
|
10.2174/1871525714666161216100044
|
0
|
45 |
Genetic Imbalance in Patients with Cervical Artery Dissection.
|
Current Genomics
|
Caspar Grond-Ginsbach; Bowang Chen; Michael Krawczak; Rastislav Pjontek; Philip Ginsbach; Yanxiang Jiang; Sherine Abboud; M. Arnold; Anna Bersano; Tobias Brandt; Valeria Caso; Stéphanie Debette; Martin Dichgans; Andreas Geschwendtner; Giacomo Giaca
|
10.2174/1389202917666160805152627
|
15
|
46 |
Genetic Influences in Cannabis Use Disorder and Psychosis: Dopamine and Beyond.
|
Current Pharmaceutical Design
|
Amine Benyamina; Laurent Karila; Geneviève Lafaye; Lisa Blecha
|
10.2174/1381612822666160831095707
|
6
|
47 |
The mir-221/222 Cluster is a Key Player in Vascular Biology via the Fine-Tuning of Endothelial Cell Physiology
|
Current Vascular Pharmacology
|
Tanja Ćelić; Valérie Metzinger-Le Meuth; Isabelle Six; Ziad A. Massy; Laurent Metzinger
|
10.2174/1570161114666160914175149
|
25
|
48 |
Review of PI3K/mTOR Inhibitors Entering Clinical Trials to Treat Triple Negative Breast Cancers.
|
Recent Patents On Anti-cancer Drug Discovery
|
Amélie Fouqué; Mickael Jean; Pierre Van de Weghe; Patrick Legembre
|
10.2174/1574892811666160519113731
|
21
|
49 |
Cutaneous and Mixed Nerve Silent Period Recordings in Symptomatic Paroxysmal Kinesigenic Dyskinesia.
|
The Open Neurology Journal
|
J. Cogez; Olivier Etard; Nathalie Derache; Gilles Defer
|
10.2174/1874205x01610010009
|
2
|
50 |
AMPK in Neurodegenerative Diseases: Implications and Therapeutic Perspectives
|
Current Drug Targets
|
Claudia Marinangeli; Sébastien Didier; Valérie Vingtdeux
|
10.2174/1389450117666160201105645
|
21
|
51 |
Targeting Kinases in Cancer Therapies: Adverse Effects on Blood Platelets.
|
Current Pharmaceutical Design
|
Marie Levade; Sonia Severin; Marie-Pierre Gratacap; Loic Ysebaert; Bernard Payrastre
|
10.2174/1381612822666160226132630
|
12
|
52 |
Vaccination and Induction of Autoimmune Diseases
|
Inflammation & Allergy Drug Targets
|
Eric Toussirot; Matthieu Béreau
|
10.2174/1871528114666160105113046
|
14
|
53 |
Challenges and Successes Using Nanomedicines for Aerosol Delivery to the Airways
|
Current Gene Therapy
|
P. Resnier; Angélique Mottais; Yann Sibiril; T. Le Gall; Tristan Montier
|
10.2174/1566523216666160104142013
|
7
|
54 |
"My Life Needs Editing" (Mort Sahl) and Genome Editing Needs Ethics.
|
Current Gene Therapy
|
Ignacio Anegon; Tuan H. Nguyen
|
10.2174/1566523216999160128110659
|
2
|
55 |
Natural and Induced Antibody Polyreactivity.
|
Anti-cancer Agents In Medicinal Chemistry
|
Annaelle Jarossay; Maya Hadzhieva; Srinivas V. Kaveri; Sébastien Lacroix-Desmazes; Jordan D. Dimitrov
|
10.2174/1871520615666150716104935
|
4
|
56 |
Autophagy : Moving Benchside Promises to Patient Bedsides.
|
Current Cancer Drug Targets
|
Amine Belaid; Papa Diogop Ndiaye; Harilaos Filippakis; Jérémie Roux; Eric Rottinger; Yacine Graba; Patrick Brest; Paul Hofman; Baharia Mograbi
|
10.2174/156800961508151001102452
|
11
|
57 |
Monocytes, Macrophages and Other Inflammatory Mediators of Abdominal Aortic Aneurysm.
|
Current Pharmaceutical Design
|
Stephane Potteaux; Alain Tedgui
|
10.2174/1381612821666150826093855
|
16
|
58 |
Why Anticancer Nanomedicine Needs Sugars
|
Current Medicinal Chemistry
|
Elise Bouffard; K. El Cheikh; Audrey Gallud; A. B. F. da Silva; Marie Maynadier; Ilaria Basile; Magali Gary-Bobo; Alain Morere; M. Garcia
|
10.2174/0929867322666150805103104
|
3
|
59 |
ACE Inhibitor Delapril Prevents Ca(2+)-Dependent Blunting of IK1 and Ventricular Arrhythmia in Ischemic Heart Disease.
|
Current Molecular Medicine
|
Jérôme Thireau; Santiago Zalvidea; Pieere Meschin; Jean-Luc Pasquié; Franck Aimond; Sylvain Richard
|
10.2174/1566524015666150831131459
|
6
|
60 |
Therapy for Dominant Inherited Diseases by Allele-Specific RNA Interference: Successes and Pitfalls
|
Current Gene Therapy
|
Delphine Trochet; Bernard Prudhon; Stéphane Vassilopoulos; Marc Bitoun
|
10.2174/1566523215666150812115730
|
11
|
61 |
Off-label treatments for mental health: inappropriate or unavoidable? a special issue to help get through the maze
|
Current Pharmaceutical Design
|
Benjamin Rolland; Ali Amad
|
10.2174/138161282123150723153610
|
1
|
62 |
Targeting Transcription Factor Binding to DNA by Competing with DNA Binders as an Approach for Controlling Gene Expression.
|
Current Topics In Medicinal Chemistry
|
Mohamed Amine Bouhlel; Mélanie Lambert; Marie-Hélène David-Cordonnier
|
10.2174/1568026615666150413154713
|
27
|
63 |
Synthetic Cathinones: A New Public Health Problem
|
Current Neuropharmacology
|
Laurent Karila; Bruno Mégarbane; Olivier Cottencin; Michel Lejoyeux
|
10.2174/1570159x13666141210224137
|
160
|
64 |
Novel synthetic pharmacophores inducing a stabilization of cellular microtubules.
|
Current Cancer Drug Targets
|
Anne Martinez; Emmanuelle Soleilhac; Caroline Barette; Renaud Prudent; Gustavo Jabor Gozzi; Emilie Vassal-Stermann; Catherine Pillet; Attilio Di Pietro; Marie-Odile Fauvarque; Laurence Lafanechère
|
10.2174/1568009615666141215154149
|
3
|
65 |
Common pathways in health benefit properties of RSV in cardiovascular diseases, cancers and degenerative pathologies.
|
Current Pharmaceutical Biotechnology
|
null Aires; Dominique Delmas
|
10.2174/1389201016666150118132457
|
15
|
66 |
Preclinical Evaluation of Efficacy and Safety of an Improved Lentiviral Vector for the Treatment of β-Thalassemia and Sickle Cell Disease
|
Current Gene Therapy
|
Olivier Negre; Cynthia C. Bartholomae; Yves Beuzard; Marina Cavazzana; Lauryn Christiansen; Celine Courne; Annette Deichmann; Maria Denaro; Edouard de Dreuzy; Mitchell Finer; Raffaele Fronza; Beatrix Gillet-Legrand; Christophe Joubert; Robert H. Kutner; P
|
10.2174/1566523214666141127095336
|
62
|
67 |
Novel strategies for preventing diabetes and obesity complications with natural polyphenols.
|
Current Medicinal Chemistry
|
Christian Carpéné; Saioa Gómez-Zorita; S. Deleruyelle; M.A. Carpene
|
10.2174/0929867321666140815124052
|
34
|
68 |
Codon Swapping of Zinc Finger Nucleases Confers Expression in Primary Cells and In Vivo from a Single Lentiviral Vector
|
Current Gene Therapy
|
Cecilia Abarrategui-Pontes; Alison Creneguy; Reynald Thinard; Eli J. Fine; Virginie Thepenier; Laure Fournier Le Ray; Thomas J. Cradick; Gang Bao; Laurent Tesson; Guillaume Podevin; Ignacio Anegon; Tuan Huy Nguyen
|
10.2174/156652321405140926161748
|
7
|
69 |
A suicide gene therapy combining the improvement of cyclophosphamide tumor cytotoxicity and the development of an anti-tumor immune response.
|
Current Gene Therapy
|
Walid Touati; Thi Anh-Dao Tran; Johanne Seguin; Monique Diry; Jean-Pierre Flinois; Claude Baillou; Géraldine Lescaille; François André; Eric Tartour; François M. Lemoine; Philippe Beaune; Isabelle de Waziers
|
10.2174/1566523214666140424152734
|
12
|
70 |
Cardioprotective effects of the Ιf current inhibition by ivabradine during cardiac dysfunction.
|
Current Pharmaceutical Biotechnology
|
Jin B Su
|
10.2174/1389201015666140515143624
|
2
|
71 |
The risk of progressive multifocal leukoencephalopathy under biological agents used in the treatment of chronic inflammatory diseases.
|
Inflammation & Allergy Drug Targets
|
Eric Toussirot; Matthieu Bereau
|
10.2174/1871528113666140224103712
|
19
|
72 |
Structure and function of MPN (Mpr1/Pad1 N-terminal) domain-containing proteins.
|
Current Protein & Peptide Science
|
Melissa Birol; Aude Echalier
|
10.2174/1389203715666140221095109
|
15
|
73 |
Metabolic features of melanoma: a gold mine of new therapeutic targets?
|
Current Cancer Drug Targets
|
Philippe Marchetti; Pierre Guerreschi; Jerome Kluza; Laurent Mortier
|
10.2174/1568009614666140407113124
|
7
|
74 |
Preface: In 2013 gene therapy is a Nike; for 2014, just do it!
|
Current Gene Therapy
|
Ignacio Anegon
|
10.2174/156652321402140318170226
|
2
|
75 |
Connexins in renal endothelial function and dysfunction.
|
Cardiovascular & Hematological Disorders Drug Targets
|
Ahmed Abed; Jean-Claude Dussaule; Jean-Jacques Boffa; Christos Chatziantoniou; Christos E. Chadjichristos
|
10.2174/1871529x14666140401105827
|
9
|
76 |
Human ABC transporters at blood-CNS interfaces as determinants of CNS drug penetration.
|
Current Pharmaceutical Design
|
Catarina Chaves; Ramzi Shawahna; Aude Jacob; Jean-Michel Scherrmann; Xavier Declèves
|
10.2174/13816128113199990466
|
25
|
77 |
Systems medicine approaches for the definition of complex phenotypes in chronic diseases and ageing. From concept to implementation and policies.
|
Current Pharmaceutical Design
|
Jean Bousquet; Christian Jorgensen; Michel Dauzat; Alfredo Cesario; Thierry Camuzat; Rodolphe Bourret; Nicolas Best; Josep M. Antó; Frédéric Abecassis; Pierre Aubas; A. Avignon; Mélanie Badin; Anna Bedbrook; Hubert Blain; Arnau
|
10.2174/1381612820666140314115505
|
52
|
78 |
Chemical metabolic inhibitors for the treatment of blood-borne cancers.
|
Anti-cancer Agents In Medicinal Chemistry
|
Martin Villalba; Nuria Lopez-Royuela; Ewelina Krzywinska; Moeez Ghani Rathore; Robert A. Hipskind; Houda Haouas; Nerea Allende-Vega
|
10.2174/18715206113136660374
|
21
|
79 |
Quantifying Gp96/Grp94 complexes preparations for vaccines: a key step often inaccurate.
|
Current Medicinal Chemistry
|
A. Seignez; Evelyne Kohli; Carmen Garrido; Renaud Seigneuric
|
10.2174/09298673113206660304
|
0
|
80 |
Janus Kinase Inhibition with Tofacitinib: Changing the Face of Inflammatory Bowel Disease Treatment
|
Current Drug Targets
|
Lucine Vuitton; Stéphane Koch; Laurent Peyrin-Biroulet
|
10.2174/13894501113149990160
|
32
|
81 |
Therapeutic perspectives for cN-II in cancer.
|
Current Medicinal Chemistry
|
Lars Petter Jordheim; Laurent Chaloin
|
10.2174/0929867311320340008
|
17
|
82 |
Astrocytes and Gliotransmitters: New Players in the Treatment of Major Depression?
|
Current Drug Targets
|
Adeline Etievant; Laura Lambás-Señas; H. Scarna; Guillaume Lucas; Nasser Haddjeri
|
10.2174/13894501113149990197
|
12
|
83 |
Chromosomal excision of a new pathogenicity island modulates Salmonella virulence in vivo.
|
Current Gene Therapy
|
Hugo E. Tobar; Franciso J. Salazar-Echegarai; Pamela A. Nieto; Christian E. Palavecino; Valentina P. Sebastián; Claudia A. Riedel; Alexis M. Kalergis; Susan M. Bueno
|
10.2174/1566523211313040002
|
7
|
84 |
The emerging role of connexin 43 in testis pathogenesis.
|
Current Molecular Medicine
|
Daniel Chevallier; D. Carette; Jerome Gilleron; D. Segretain; G. Pointis
|
10.2174/15665240113139990066
|
6
|
85 |
Ca(2+) fluxes involvement in gene expression during cardiac hypertrophy.
|
Current Vascular Pharmacology
|
Ana María Gómez; Gema Ruiz-Hurtado; Jean-Pierre Benitah; Alejandro Domínguez-Rodríguez
|
10.2174/1570161111311040013
|
29
|
86 |
Von Willebrand factor and thrombosis: risk factor, actor and pharmacological target.
|
Current Vascular Pharmacology
|
Peter J. Lenting; Cécile V. Denis; Nikolett Wohner
|
10.2174/1570161111311040008
|
11
|
87 |
Understanding Respiratory Syncytial Virus Infection to Improve Treatment and Immunity
|
Current Molecular Medicine
|
Pablo A. González; Leandro J. Carreño; Susan M. Bueno; Claudia A. Riedel; Alexis M. Kalergis
|
10.2174/1566524011313070007
|
11
|
88 |
Pathophysiology of NASH: perspectives for a targeted treatment.
|
Current Pharmaceutical Design
|
Fabio Marra; Sophie Lotersztajn
|
10.2174/13816128113199990344
|
99
|
89 |
How Recent Advances in High-risk Myelodysplastic Syndrome Physiopathology May Impact Future Treatments
|
Current Pharmaceutical Design
|
Thomas Cluzeau; Guillaume Robert; Arnaud Jacquel; Patrick Auberger
|
10.2174/13816128113199990334
|
3
|
90 |
Role of descending aminergic pathways in the development of locomotion.
|
Current Pharmaceutical Design
|
Edouard Pearlstein
|
10.2174/1381612811319240002
|
8
|
91 |
"It is not superstition that worries me, Herr Doctor, but genes and chromosomes" Inspector Kemp, from the movie Young Frankenstein, 1974.
|
Current Gene Therapy
|
Ignacio Anegon
|
|
0
|
92 |
The multiple aspects of stroke and stem cell therapy.
|
Current Molecular Medicine
|
Onteniente B
|
10.2174/1566524011313050013
|
12
|
93 |
Human Pluripotent Stem Cells for Modelling Human Liver Diseases and Cell Therapy
|
Current Gene Therapy
|
Noushin Dianat; Clara Steichen; Ludovic Vallier; Anne M. Weber; Anne Dubart-Kupperschmitt
|
10.2174/1566523211313020006
|
46
|
94 |
Editorial (hot topic: stem-cell reprogramming for medicine).
|
Current Gene Therapy
|
Tuan H. Nguyen
|
10.2174/1566523211313020001
|
0
|
95 |
Monoclonal Anti-TNF-α Antibodies for Severe Steroid-Dependent Asthma: A Case Series.
|
The Open Respiratory Medicine Journal
|
Camille Taillé; Claire Poulet; Sylvain Marchand-Adam; Raphael Borie; Marie-Christine Dombret; Bruno Crestani; Michel Aubier
|
10.2174/1874306401307010021
|
29
|
96 |
Comparative Efficacy and Safety Study of Two Chondroitin Sulfate Preparations from Different Origin (Avian and Bovine) in Symptomatic Osteoarthritis of the Knee
|
The Open Rheumatology Journal
|
Patrice Fardellone; Mohammed Zaim; Anne-Sophie Saurel; Emmanuel Maheu
|
10.2174/1874312901307010001
|
14
|
97 |
Calcium channels and prostate cancer.
|
Recent Patents On Anti-cancer Drug Discovery
|
George Shapovalov; Roman Skryma; Natalia Prevarskaya
|
10.2174/15748928130103
|
29
|
98 |
The need for calcium channels in cell proliferation.
|
Recent Patents On Anti-cancer Drug Discovery
|
Thierry Capiod
|
10.2174/15748928130102
|
51
|
99 |
Human Stem Cells and Articular Cartilage Tissue Engineering
|
Current Pharmaceutical Biotechnology
|
J.F. Stoltz; Céline Huselstein; Jessica Schiavi; Yin-Ping Li; D. Bensoussan; Véronique Decot; N. de Isla
|
10.2174/138920112804724846
|
7
|
100 |
The Tribbles-1 protein in humans: roles and functions in health and disease.
|
Current Molecular Medicine
|
Emilie Dugast; Endre Kiss-Toth; Jean-Paul Soulillou; Sophie Brouard; Joanna Ashton-Chess
|
10.2174/1566524011307010080; 10.2174/156652413804486197
|
15
|
101 |
Diagnosis and consequences of cocaine addiction.
|
Current Medicinal Chemistry
|
Laurent Karila; A. Petit; W. Lowenstein; M. Reynaud
|
10.2174/092986712803988839
|
48
|
102 |
A new model for determining the MTD during phase-I trials in pediatric oncology.
|
Current Topics In Medicinal Chemistry
|
Christian Faivre; D. Barbolosi; Athanassios Iliadis
|
10.2174/156802612803531469
|
2
|
103 |
Mitochondrial dysfunction and lipid homeostasis.
|
Current Drug Metabolism
|
Joseph Vamecq; Anne-Frédérique Dessein; Monique Fontaine; Gilbert Briand; Nicole Porchet; Norbert Latruffe; Pierre Andreolotti; Mustapha Cherkaoui-Malki
|
10.2174/138920012803762792
|
31
|
104 |
Search for Distinctive Markers in DNT and Cortical Grade II Glioma in Children: Same Clinicopathological and Molecular Entities?
|
Current Topics In Medicinal Chemistry
|
Laetitia Padovani; Carole Colin; Carla Fernandez; André Maues de Paula; Sandy Mercurio; Didier Scavarda; Frederic Frassineti; José Adélaïde; Anderson Loundou; Dominique Intagliata; Corinne Bouvier; Gabriel Lena; Daniel Birnbaum;
|
10.2174/156802612803531450
|
10
|
105 |
Pharmacogenetics of Clopidogrel
|
Current Pharmaceutical Design
|
Stephen A. O’Connor; Jean-Sébastien Hulot; Johanne Silvain; Guillaume Cayla; Gilles Montalescot; Jean Philippe Collet
|
10.2174/138161212803251880
|
8
|
106 |
Mitochondria As Potential Targets of Flavonoids: Focus on Adipocytes and Endothelial Cells
|
Current Medicinal Chemistry
|
Lucie Duluc; Raffaella Soleti; Nicolas Clere; Ramaroson Andriantsitohaina; Gilles Simard
|
10.2174/092986712803251467
|
12
|
107 |
Capsule endoscopy in Crohn's disease.
|
Current Drug Targets
|
Jean-Baptiste Chevaux; Gionata Fiorino; Muriel Frederic; Laurent Peyrin-Biroulet
|
10.2174/138945012802429732
|
3
|
108 |
Protein-Protein Interactions in Drug Discovery - A Leap into the Chemical Space of Protein-Protein Interaction Inhibitors
|
Current Pharmaceutical Design
|
Bruno O. Villoutreix; Céline M. Labbé; David Lagorce; Guillaume Laconde; Olivier Sperandio
|
10.2174/138161212802651571
|
49
|
109 |
Splicing Modulation Mediated by Small Nuclear RNAs as Therapeutic Approaches for Muscular Dystrophies
|
Current Gene Therapy
|
Rachid Benchaouir; Aurélie Goyenvalle
|
10.2174/156652312800840586
|
6
|
110 |
IL-10 Producing Regulatory B Cells in Mice and Humans: State of the Art
|
Current Molecular Medicine
|
Jean-David Bouaziz; H. Le Buanec; Anne Saussine; Armand Bensussan; Martine Bagot
|
10.2174/156652412800620057
|
47
|
111 |
Role of the endosomal ESCRT machinery in HIV-1 Vpu-induced down-regulation of BST2/tetherin.
|
Current HIV Research
|
Katy Janvier; Nicolas Roy; Clarisse Berlioz-Torrent
|
10.2174/157016212800792414
|
11
|
112 |
Potential anti-catabolic and anabolic properties of strontium ranelate.
|
Current Molecular Pharmacology
|
Romuald Mentaverri; Michel Brazier; Saïd Kamel; Patrice Fardellone
|
10.2174/1874467211205020189
|
11
|
113 |
Evaluation of Early Regenerative Processes in a Preclinical Pig Model of Acute Kidney Injury
|
Current Molecular Medicine
|
Ludivine Rossard; Frederic Favreau; Julie Demars; R. Robert; Cedric Nadeau; Jerome Cau; Raphael Thuillier; Thierry Hauet
|
10.2174/156652412800163334; 10.2174/1566524011207040502
|
10
|
114 |
Targeting phospho-Ser422 by active Tau Immunotherapy in the THYTau22 mouse model: a suitable therapeutic approach
|
Current Alzheimer Research
|
Laetitia Troquier; Raphaëlle Caillierez; Sylvie Burnouf; Francisco J. Fernandez-Gomez; Marie-Eve Grosjean; Nadège Zommer; Nicolas Sergeant; Susanna Schraen-Maschke; David Blum; Luc Buée
|
10.2174/156720512800492503
|
148
|
115 |
Retinoid Receptors and Therapeutic Applications of RAR/RXR Modulators
|
Current Topics In Medicinal Chemistry
|
Albane le Maire; Susana Álvarez; Pattabhiraman Shankaranarayanan; Angel R. de Lera; William Bourguet; Hinrich Gronemeyer
|
10.2174/156802612799436687
|
63
|
116 |
Evolution of class A G-protein-coupled receptors: implications for molecular modeling.
|
Current Medicinal Chemistry
|
Marie Chabbert; Hélène Castel; Julien Pelé; Julie Deville; R. Legendre; Patrice Rodien
|
10.2174/092986712799320600
|
10
|
117 |
ACE inhibition prevents diastolic Ca2+ overload and loss of myofilament Ca2+ sensitivity after myocardial infarction.
|
Current Molecular Medicine
|
Santiago Zalvidea; Lucas Andre; Xavier Loyer; Cécile Cassan; Yannis Sainte-Marie; Jérôme Thireau; Ivar Sjaastad; Christophe Heymes; Jean-Luc Pasquié; Olivier Cazorla; Franck Aimond; Sylvain Richard
|
10.2174/156652412798889045
|
11
|
118 |
Potential anticancer properties of bisphosphonates: insights from preclinical studies.
|
Anti-cancer Agents In Medicinal Chemistry
|
Philippe Clézardin
|
10.2174/187152012799014977
|
26
|
119 |
Possible Pathogenic Role of the Transmembrane Isoform of CD160 NK Lymphocyte Receptor in Paroxysmal Nocturnal Hemoglobinuria
|
Current Molecular Medicine
|
Jérôme Giustiniani; S. Sabour-Alaoui; J. Bernard; Daniel Olive; C. Bos; A. Razafindratsita; Anna D. Petropoulou; R.P. de Latour; P. Le Bouteiller; Martine Bagot; Gérard Socié; Armand Bensussan; Aude Marie-Cardine
|
10.2174/156652412798889081
|
3
|
120 |
Basal breast cancer: a complex and deadly molecular subtype.
|
Current Molecular Medicine
|
François Bertucci; P. Finetti; Daniel Birnbaum
|
10.2174/156652412798376134
|
131
|
121 |
The family B1 GPCR: structural aspects and interaction with accessory proteins.
|
Current Drug Targets
|
Alain Couvineau; Marc Laburthe
|
10.2174/138945012798868434
|
32
|
122 |
Structure and modeling of knottins, a promising molecular scaffold for drug discovery.
|
Current Pharmaceutical Design
|
Jérôme Gracy; Laurent Chiche
|
10.2174/138161211798999339
|
23
|
123 |
Chemical Connexin Impairment in the Developing Gonad Associated with Offspring Infertility
|
Current Medicinal Chemistry
|
Jerome Gilleron; A. Malassine; D. Carette; D. Segretain; Georges Pointis
|
10.2174/092986711797636117
|
7
|
124 |
Can Transcriptomics Cut the Gordian Knot of Amyotrophic Lateral Sclerosis
|
Current Genomics
|
Alexandre Henriques; Jose-Luis Gonzalez de Aguilar
|
10.2174/138920211797904043
|
15
|
125 |
Regulation of autophagy by sphingolipids.
|
Anti-cancer Agents In Medicinal Chemistry
|
Carmen Bedia; Thierry Levade; Patrice Codogno
|
10.2174/187152011797655131
|
43
|
126 |
Active-targeted nanotherapy strategies for prostate cancer.
|
Current Cancer Drug Targets
|
M. Katsogiannou; Ling Peng; C. V. Catapano; P. Rocchi
|
10.2174/156800911797264770
|
15
|
127 |
Therapeutic Potential of Peptide Toxins that Target Ion Channels
|
Inflammation & Allergy Drug Targets
|
Beraud E; Chandy Kg
|
10.2174/187152811797200696
|
16
|
128 |
Regulating TRAIL receptor-induced cell death at the membrane : a deadly discussion.
|
Recent Patents On Anti-cancer Drug Discovery
|
Sarah Shirley; Alexandre Morizot; Olivier Micheau
|
10.2174/157489211796957757
|
53
|
129 |
Regulation of Endothelial Nitric Oxide Synthase in Pathophysiological Conditions
|
Cardiovascular & Hematological Disorders Drug Targets
|
Esma R. Isenovic; Sanja Soskic; Hans-Dirk Dungen; Branislava Dobutovic; Tahirovic Elvis; Inkrot Simone; Pierre Marche
|
10.2174/187152911798346972
|
13
|
130 |
Regulation of death and growth signals at the plasma membrane by sphingomyelin synthesis: implications for hematological malignancies.
|
Recent Patents On Anti-cancer Drug Discovery
|
Elodie Lafont; Kazuyuki Kitatani; Toshiro Okazaki; Bruno Ségui
|
10.2174/157489211796957801
|
8
|
131 |
Kinins as Therapeutic Agents in Cardiovascular and Renal Diseases
|
Current Pharmaceutical Design
|
François Alhenc-Gelas; Nadine Bouby; Christine Richer; Louis Potier; Ronan Roussel; Michel Marre
|
10.2174/138161211797416002
|
19
|
132 |
Dietary omega 3 polyunsaturated fatty acids and Alzheimer's disease: interaction with apolipoprotein E genotype
|
Current Alzheimer Research
|
Pascale Barberger-Gateau; Cécilia Samieri; Catherine Féart; Mélanie Plourde
|
10.2174/156720511796391926
|
91
|
133 |
The role of the urokinase receptor in epilepsy, in disorders of language, cognition, communication and behavior, and in the central nervous system.
|
Current Pharmaceutical Design
|
Nadine Bruneau; Pierre Szepetowski
|
10.2174/138161211796718198
|
24
|
134 |
Effects of nutrients on postprandial lipemia.
|
Current Vascular Pharmacology
|
Denis Lairon; Catherine Defoort
|
10.2174/157016111795495576
|
22
|
135 |
Pharmacotherapy for smoking cessation: present and future.
|
Current Pharmaceutical Design
|
Henri-Jean Aubin; Laurent Karila; Michel Reynaud
|
10.2174/138161211796150837
|
31
|
136 |
Pharmacological Treatments of Opiate Dependence
|
Current Pharmaceutical Design
|
Amine Benyamina; Michel Reynaud; Lisa Blecha; Laurent Karila
|
10.2174/138161211796150855
|
5
|
137 |
Modulation of HIV Binding to Epithelial Cells and HIV Transfer from Immature Dendritic Cells to CD4 T Lymphocytes by Human Lactoferrin and its Major Exposed LF-33 Peptide
|
The Open Virology Journal
|
Laetitia Carthagena; Pierre Becquart; Hakim Hocini; Michel D. Kazatchkine; Hicham Bouhlal; Laurent Bélec
|
10.2174/1874357901105010027
|
10
|
138 |
Identification and induction of cytochrome P450s involved in the metabolism of flavone-8-acetic acid in mice.
|
Drug Metabolism Letters
|
Minh Hien Pham; Hervé Rhinn; Nicolas Auzeil; Anne Regazzetti; Djamel Eddine Harami; Daniel Scherman; Guy G. Chabot
|
10.2174/187231211795305221
|
3
|
139 |
VIP-induced neuroprotection of the developing brain
|
Current Pharmaceutical Design
|
Sandrine Passemard; Paulina Sokolowska; Leslie Schwendimann; Pierre Gressens
|
10.2174/138161211795589409
|
22
|
140 |
Resveratrol, a phytochemical inducer of multiple cell death pathways: apoptosis, autophagy and mitotic catastrophe.
|
Current Medicinal Chemistry
|
Dominique Delmas; Eric Solary; Norbert Latruffe
|
10.2174/092986711795029708
|
124
|
141 |
EHT0202 in Alzheimer's disease: a 3-month, randomized, placebo-controlled, double-blind study.
|
Current Alzheimer Research
|
Bruno Vellas; Olivier Sol; Peter J. Snyder; Pierre-Jean Ousset; Raphael Haddad; Mylene Maurin; Jean-Christophe Lemarie; Laurent Desire; Matthew P. Pando
|
10.2174/156720511795256053
|
80
|
142 |
Adipose Tissue as a Target of HIV-1 Antiretroviral Drugs. Potential Consequences on Metabolic Regulations
|
Current Pharmaceutical Design
|
Martine Caron-Debarle; Franck Boccara; Claire Lagathu; Bénédicte Antoine; Pascale Cervera; Jean-Philippe Bastard; Corinne Vigouroux; Jacqueline Capeau
|
10.2174/138161210793563446
|
33
|
143 |
Skeletal muscle in motor neuron diseases: therapeutic target and delivery route for potential treatments.
|
Current Drug Targets
|
Luc Dupuis; Andoni Echaniz-Laguna
|
10.2174/1389450111007011250
|
35
|
144 |
Assessment of Bishosphonate Activity In Vitro
|
Current Pharmaceutical Design
|
L. Mitrofan; Seppo Auriola; H. Monkkonen; Jukka Monkkonen
|
10.2174/138161210793563644
|
2
|
145 |
Therapeutic Approach of Primary Bone Tumours by Bisphosphonates
|
Current Pharmaceutical Design
|
Gatien Moriceau; Benjamin Ory; Bérengère Gobin; Franck Verrecchia; François Gouin; Frédéric Blanchard; Françoise Rédini; Dominique Heymann
|
10.2174/138161210793563554
|
36
|
146 |
Alternative Use of Bisphosphonate Therapy for Rheumatic Disease
|
Current Pharmaceutical Design
|
B. Le Goff; Jean-Marie Berthelot; Yves Maugars; Evange Romas
|
10.2174/138161210793563626
|
14
|
147 |
A Comparison Between Bisphosphonates and Other Treatments for Osteoporosis
|
Current Pharmaceutical Design
|
B. Le Goff; P. Guillo; Joëlle Glémarec; J.-M. Berthelot; Yves Maugars
|
10.2174/138161210793563563
|
8
|
148 |
Emerging concepts for the treatment of hematological malignancies with therapeutic monoclonal antibodies.
|
Current Drug Targets
|
Aude-Hélène Capietto; Samarh Keirallah; Emilie Gross; Nicolas Dauguet; Emilie Laprevotte; Christine Jean; Julie Gertner-Dardenne; Christine Bezombes; Anne Quillet-Mary; Mary Poupot; Loic Ysebaert; Guy Laurent; Jean-Jacques Fournié
|
10.2174/138945010791320845
|
8
|
149 |
Vascular and endothelial regeneration.
|
Current Stem Cell Research & Therapy
|
Louis Casteilla; Valérie Planat-Benard; Béatrice Cousin; Patrick Laharrague; Philippe Bourin
|
10.2174/157488810791268546
|
16
|
150 |
Determinants of smoking cessation attempts among HIV-infected patients results from a hospital-based prospective cohort.
|
Current HIV Research
|
Gaëlle Encrenaz; Antoine Bénard; Virginie Rondeau; Fabrice Bonnet; Estibaliz Lazaro; Didier Neau; Michel Dupon; François Dabis; Patrick Mercié; Geneviève Chêne
|
10.2174/157016210791111089
|
10
|
151 |
Pediatric idiopathic nephrotic syndrome: treatment strategies in steroid dependent and steroid resistant forms.
|
Current Medicinal Chemistry
|
Ulinski T; Aoun B
|
10.2174/092986710790712174
|
15
|
152 |
Cellular Senescence is a Common Characteristic Shared by Preneoplasic and Osteo-Arthritic Tissue.
|
The Open Rheumatology Journal
|
Jean-Marc Brondello; Didier Philipot; Farida Djouad; Christian Jorgensen; Danièle Noël
|
10.2174/1874312901004010010
|
9
|
153 |
Efficacy of TNF antagonists beyond one year in adult and pediatric inflammatory bowel diseases: a systematic review.
|
Current Drug Targets
|
Abderrahim Oussalah; Silvio Danese; Laurent Peyrin-Biroulet
|
10.2174/138945010790309939
|
41
|
154 |
Interaction and structural modification of topoisomerase IIα by peptidyl prolyl isomerase, pin1: An In Silico study
|
Protein And Peptide Letters
|
Rohit Mathur; Shubhanker Suman; Nicolas Beaume; Mashook Ali; Anant Narayan Bhatt; Madhu Chopra; Daman Saluja; Anil K. Mishra; Sudhir Chandna; Pramesh N. Kapoor; Bilikere S. Dwarakanath
|
10.2174/092986610790226030
|
2
|
155 |
Redistribution of CD95 into the lipid rafts to treat cancer cells
|
Recent Patents On Anti-cancer Drug Discovery
|
Bruno Ségui; Patrick Legembre
|
10.2174/157489210789702190
|
15
|
156 |
Structure-Based Virtual Ligand Screening: Recent Success Stories
|
Combinatorial Chemistry & High Throughput Screening
|
Bruno O. Villoutreix; Richard Eudes; Maria A. Miteva
|
10.2174/138620709789824682
|
108
|
157 |
Cartilage Tissue Engineering: Towards a Biomaterial-Assisted Mesenchymal Stem Cell Therapy
|
Current Stem Cell Research & Therapy
|
Claire Vinatier; Carine Bouffi; Christophe Merceron; Jan O. Gordeladze; Jean-Marc Brondello; Christian Jorgensen; Pierre Weiss; Jérôme Guicheux; Danièle Noël
|
10.2174/157488809789649205
|
171
|
158 |
Inhibition of Mitochondrial Membrane Permeability as a Putative Pharmacological Target for Cardioprotection
|
Current Medicinal Chemistry
|
Didier Morin; Rana Assaly; Stéphanie Paradis; Alain Berdeaux
|
10.2174/092986709789712871
|
56
|
159 |
Angiotensin, the hormone to be blocked by antithypertensive drugs, and perhaps why they don't work.
|
Current Vascular Pharmacology
|
Simon N. Thornton
|
10.2174/157016109789043874
|
3
|
160 |
Cosignaling molecules around LIGHT-HVEM-BTLA: from immune activation to therapeutic targeting.
|
Current Molecular Medicine
|
Christine Pasero; Alemseged Truneh; Daniel Olive
|
10.2174/156652409789105589
|
14
|
161 |
Expression and Function of Kruppel Like-Factors (KLF) in Carcinogenesis.
|
Current Genomics
|
Christophe Bureau; Naïma Hanoun; Jérôme Torrisani; Jean-Pierre Vinel; Louis Buscail; Pierre Cordelier
|
10.2174/138920209788921010
|
61
|
162 |
How do HIV-infected smokers react to cigarette price increases? Evidence from the APROCO-COPILOTE-ANRS CO8 Cohort.
|
Current HIV Research
|
Patrick Peretti-Watel; Virginie Villes; Xavier Duval; Fidéline Collin; Jacques Reynes; Alain Sobel; Camelia Protopopescu; Geneviève Chêne; Bruno Spire; François Raffi
|
10.2174/157016209788680624
|
8
|
163 |
Neutrophil apoptosis during viral infections.
|
The Open Virology Journal
|
Carole Elbim; Peter D. Katsikis; Jérôme Estaquier
|
10.2174/1874357900903010052
|
22
|
164 |
Novel implications for lysophospholipids, lysophosphatidic acid and sphingosine 1-phosphate, as drug targets in cancer.
|
Anti-cancer Agents In Medicinal Chemistry
|
Olivier Peyruchaud
|
10.2174/1871520610909040381
|
20
|
165 |
In Vivo Localization of Fas-Associated Death Domain Protein in the Nucleus and Cytoplasm of Normal Thyroid and Liver Cells
|
The Open Autoimmunity Journal
|
Léa Tourneur; Alain Schmitt; Gilles Chiocchia
|
10.2174/1876894600901010027
|
2
|
166 |
Early Tau pathology involving the septo-hippocampal pathway in a Tau transgenic model: relevance to Alzheimer's disease.
|
Current Alzheimer Research
|
Karim Belarbi; Katharina Schindowski; Sylvie Burnouf; Raphaëlle Caillierez; Marie-Eve Grosjean; Dominique Demeyer; Malika Hamdane; Nicolas Sergeant; David Blum; Luc Buée
|
10.2174/156720509787602843
|
38
|
167 |
Current Screens Based on the AlphaScreen™ Technology for Deciphering Cell Signalling Pathways
|
Current Genomics
|
Saïd Taouji; Sophie Dahan; Roger Bossé; Eric Chevet
|
10.2174/138920209787847041
|
41
|
168 |
Ex vivo liver-directed gene therapy for the treatment of metabolic diseases: advances in hepatocyte transplantation and retroviral vectors.
|
Current Gene Therapy
|
Tuan Huy Nguyen; Sylvie Mainot; Panagiotis Lainas; Marie-Thérèse Groyer-Picard; Dominique Franco; Ibrahim Dagher; Anne M. Weber
|
10.2174/156652309787909481
|
29
|
169 |
Pre-Clinical and Clinical Evaluation of Nuclear Tracers for the Molecular Imaging of Vulnerable Atherosclerosis: An Overview
|
Current Medicinal Chemistry
|
Laurent Riou; Alexis Broisat; Julien Dimastromatteo; Guillaume Pons; Daniel Fagret; Catherine Ghezzi
|
10.2174/092986709787909596
|
21
|
170 |
Renal Protective Effect of Metabolic Therapy in Patients with Coronary Artery Disease and Diabetes : From Bench to Bed Side
|
Current Pharmaceutical Design
|
Raphael Thuillier; Jean Paul Tillement; Thierry Hauet
|
10.2174/138161209787582110
|
4
|
171 |
Structure-function relationship of Vpr: biological implications.
|
Current HIV Research
|
Nelly Morellet; Bernard P. Roques; Serge Bouaziz
|
10.2174/157016209787581490
|
38
|
172 |
Procedure for identification and characterization of drugs efficient against mammalian prion: from a yeast-based antiprion drug screening assay to in vivo mouse models.
|
Infectious Disorders Drug Targets
|
Cécile Voisset; Sven J. Saupe; Hervé Galons; Marc Blondel
|
10.2174/1871526510909010031
|
9
|
173 |
Multivalent-Based Drug Design Applied to Serotonin 5-HT4 Receptor Oligomers
|
Current Pharmaceutical Design
|
Frank Lezoualc'h; Ralf Jockers; Isabelle Berque-Bestel
|
10.2174/138161209787315602
|
13
|
174 |
The potential anti-tumorigenic and anti-metastatic side of the proprotein convertases inhibitors.
|
Recent Patents On Anti-cancer Drug Discovery
|
Rachid Lahlil; Fabien Calvo; Abdel-Majid Khatib
|
10.2174/157489209787002470
|
9
|
175 |
CDC25A: a rebel within the CDC25 phosphatases family?
|
Anti-cancer Agents In Medicinal Chemistry
|
Anne Fernandez-Vidal; Anne Mazars; Stéphane Manenti
|
10.2174/187152008786847684
|
32
|
176 |
Bivalent Ligands as Specific Pharmacological Tools for G Protein-Coupled Receptor Dimers
|
Current Drug Discovery Technologies
|
Isabelle Berque-Bestel; Frank Lezoualc'h; Ralf Jockers
|
10.2174/157016308786733591
|
54
|
177 |
Metabolic Effects of Resveratrol in Mammals - a Link Between Improved Insulin Action and Aging
|
Current Aging Science
|
Sara Fröjdö; Christine Durand; Luciano Pirola
|
10.2174/1874609810801030145
|
36
|
178 |
PPARgamma and early human placental development.
|
Current Medicinal Chemistry
|
Thierry Fournier; Patrice Therond; Karen Handschuh; Vassilis Tsatsaris; Danièle Evain-Brion
|
10.2174/092986708786848677
|
32
|
179 |
Strategies for Targeting Lentiviral Vectors
|
Current Gene Therapy
|
Cecilia Frecha; Judit Szécsi; François-Loïc Cosset; Els Verhoeyen
|
10.2174/156652308786848003
|
68
|
180 |
Proliferation of Breast Cancer Cells: Regulation, Mediators, Targets for Therapy
|
Anti-cancer Agents In Medicinal Chemistry
|
Mester J; Redeuilh G
|
10.2174/187152008786847747
|
23
|
181 |
Chemokine network in the nervous system: a new target for pain relief.
|
Current Medicinal Chemistry
|
Romain-Daniel Gosselin; Marc-André Dansereau; Michel Pohl; Patrick Kitabgi; Nicolas Beaudet; Philippe Sarret; S. Melik Parsadaniantz
|
10.2174/092986708786242822
|
58
|
182 |
The genetic basis of sleep disorders.
|
Current Pharmaceutical Design
|
Yves Dauvilliers; Mehdi Tafti
|
10.2174/138161208786549308
|
20
|
183 |
Disturbance of apolipoprotein B100 containing lipoprotein metabolism in severe hyperlipidemic and lipodystrophic HIV patients on combined antiretroviral therapy: evidences of insulin resistance effect.
|
Medicinal Chemistry (Shariqah (United Arab Emirates))
|
Khadija Ouguerram; Yassine Zair; Stephanie Billon; Maud Chétiveaux; Cécile Brunet-François; Kalyane Ngohou-Bach; Clotilde Allavena; Véronique Reliquet; Brigitte Milpied; T. Magot
|
10.2174/157340608786242061
|
2
|
184 |
Novel Anti-Cancer Strategy in Bone Tumors by Targeting Molecular and Cellular Modulators of Bone Resorption
|
Recent Patents On Anti-cancer Drug Discovery
|
Brounais Benedicte; Ruiz V. Carmen; Rousseau Julie; Lamoureux Francois; Blanchard Frederic; Heymann Dominique; Redini Francoise
|
10.2174/157489208786242269
|
7
|
185 |
From Cochlear Cell Death Pathways To New Pharmacological Therapies
|
Mini Reviews In Medicinal Chemistry
|
Jing Wang; Jean-Luc Puel
|
10.2174/138955708785740599
|
7
|
186 |
Pharmacogenetic determinants of immediate and delayed reactions of drug hypersensitivity.
|
Current Pharmaceutical Design
|
J.L. Guéant; Rosa-Maria Guéant-Rodriguez; I. Aimone Gastin; Jose A. Cornejo-Garcia; Marinella Viola; Annick Barbaud; Paul-Michel Mertes; M. Blanca; Antonino Romano
|
10.2174/138161208786369795
|
33
|
187 |
Recent advances in the characterization of genetic factors involved in human susceptibility to infection by schistosomiasis.
|
Current Genomics
|
Amandine Isnard; Christophe Chevillard
|
10.2174/138920208785133262
|
10
|
188 |
GuidAge Study: A 5-Year Double Blind, Randomised Trial of EGb 761 for the Prevention of Alzheimers Disease in Elderly Subjects with Memory Complaints. I. Rationale, Design and Baseline Data
|
Current Alzheimer Research
|
Sandrine Andrieu; Pierre-Jean Ousset; Nicola Coley; Mehemed Ouzid; Hélène Mathiex-Fortunet; Bruno Vellas
|
10.2174/156720508785132271
|
48
|
189 |
Peptide nucleic acids (PNAs) as diagnostic devices for genetic and cytogenetic analysis.
|
Current Pharmaceutical Design
|
Franck Pellestor; Petra Paulasova; Samir Hamamah
|
10.2174/138161208785777405
|
31
|
190 |
Erythropoietic porphyrias: animal models and update in gene-based therapies.
|
Current Gene Therapy
|
Emmanuel Richard; Elodie Robert-Richard; Cécile Ged; François Moreau-Gaudry; Hubert de Verneuil
|
10.2174/156652308784746477
|
25
|
191 |
Histone deacetylase inhibitors: therapeutic agents and research tools for deciphering motor neuron diseases.
|
Current Medicinal Chemistry
|
Andoni Echaniz-Laguna; O. Bousiges; J.-P. Loeffler; A.-L. Boutillier
|
10.2174/092986708784534974
|
37
|
192 |
Dihydropyridine receptor blockade in the treatment of asthma.
|
Recent Patents On Inflammation & Allergy Drug Discovery
|
Lucette Pelletier; Jean-Charles Guéry
|
10.2174/187221308784543638
|
8
|
193 |
Alkylsquarates as Key Intermediates for the Rapid Preparation of Original Drug-Inspired Compounds
|
Combinatorial Chemistry & High Throughput Screening
|
Julie Charton; Lise Charruault; Rebecca Deprez-Poulain; Benoit Deprez
|
10.2174/138620708784246013
|
7
|
194 |
In silico-in vitro screening of protein-protein interactions: towards the next generation of therapeutics.
|
Current Pharmaceutical Biotechnology
|
Bruno O. Villoutreix; Karine Bastard; Olivier Sperandio; Robin Fåhraeus; Jean-Luc Poyet; Fabien Calvo; Benoit Deprez; Maria A. Miteva
|
10.2174/138920108783955218
|
47
|
195 |
Inhibitory Feature of the Proprotein Convertases Prosegments
|
Medicinal Chemistry (Shariqah (United Arab Emirates))
|
Yannick Bontemps; Marion Lapierre; Geraldine Siegfried; Fabien Calvo; Abdel-Majid Khatib
|
10.2174/157340608783789176
|
6
|
196 |
To Die or Not to Die: That is the Autophagic Question
|
Current Molecular Medicine
|
Lorenzo Galluzzi; Jose Miguel Vicencio; Oliver Kepp; Ezgi Tasdemir; Maria Chiara Maiuri; Guido Kroemer
|
10.2174/156652408783769616
|
229
|
197 |
Clinical progression rates by CD4 cell category before and after the initiation of combination antiretroviral therapy (cART).
|
The Open AIDS Journal
|
Marguerite Guiguet; Kholoud Porter; Andrew N. Phillips; Dominique Costagliola; Abdel Babiker
|
10.2174/1874613600802010003
|
13
|
198 |
Mesenchymal stem cells: an emerging tool for cancer targeting and therapy.
|
Current Stem Cell Research & Therapy
|
Vanessa Fritz; Christian Jorgensen
|
10.2174/157488808783489462
|
76
|
199 |
Plasmacytoid dendritic cells count in antiretroviral-treated patients is predictive of HIV load control independent of CD4+ T-cell count.
|
Current HIV Research
|
Miriam Lichtner; Raffaella Rossi; M.C. Rizza; Fabio Mengoni; Ilaria Sauzullo; Anna Paola Massetti; Giuseppe Luzi; Anne Hosmalin; Claudio Maria Mastroianni; Vincenzo Vullo
|
10.2174/157016208783571937
|
24
|
200 |
Mannose 6-phosphate receptor targeting and its applications in human diseases.
|
Current Medicinal Chemistry
|
Magali Gary-Bobo; Philippe Nirdé; Audrey Jeanjean; Alaih Morère; Marcel Garcia
|
10.2174/092986707782794005
|
102
|
201 |
Cytokines as Regulators of Atherosclerosis in Murine Models
|
Current Drug Targets
|
Ziad Mallat; Alain Tedgui
|
10.2174/138945007783220588
|
12
|
202 |
Anti-cancer therapeutic approaches based on intracellular and extracellular heat shock proteins.
|
Current Medicinal Chemistry
|
Celine Didelot; David Lanneau; M. Brunet; Anne-Laure Joly; Aurélie de Thonel; Gabriela Chiosis; Carmen Garrido
|
10.2174/092986707782360079
|
115
|
203 |
Myostatin in the pathophysiology of skeletal muscle.
|
Current Genomics
|
Gilles Carnac; Barbara Vernus; Anne Bonnieu
|
10.2174/138920207783591672
|
31
|
204 |
Multiligand endocytosis and congenital defects: roles of cubilin, megalin and amnionless.
|
Current Pharmaceutical Design
|
Renata Kozyraki; Françoise Gofflot
|
10.2174/138161207782110507
|
38
|
205 |
Antipsychotics dosage and antiparkinsonian prescriptions.
|
Clinical Practice And Epidemiology In Mental Health : CP & EMH
|
Eric Acquaviva; Isabelle Gasquet; Bruno Falissard
|
10.1186/1745-0179-3-14
|
4
|
206 |
Connexins as precocious markers and molecular targets for chemical and pharmacological agents in carcinogenesis.
|
Current Medicinal Chemistry
|
Georges Pointis; C. Fiorini; Jerome Gilleron; D. Carette; D. Segretain
|
10.2174/092986707781696564
|
60
|
207 |
Free Resources to Assist Structure-Based Virtual Ligand Screening Experiments
|
Current Protein & Peptide Science
|
Bruno O. Villoutreix; Nicolas Renault; David Lagorce; Olivier Sperandio; Matthieu Montes; Maria A. Miteva
|
10.2174/138920307781369391
|
97
|
208 |
Analgesia induced by morphine microinjected into the nucleus raphe magnus: effects on tonic pain.
|
Current Drug Delivery
|
Christian Dualé; Fernando Sierralta; Radhouane Dallel
|
10.2174/156720107781023884
|
12
|
209 |
Enjoy the Silence: The Story of let-7 MicroRNA and Cancer.
|
Current Genomics
|
Torrisani Jérôme; Parmentier Laurie; Buscail Louis; Cordelier Pierre
|
10.2174/138920207781386933
|
70
|
210 |
Potential of recombinant SV40-based vectors for gene therapy.
|
Recent Patents On DNA & Gene Sequences
|
Louis Buscail; Pierre Cordelier
|
10.2174/187221507780887045
|
2
|
211 |
mTOR Inhibitors (Rapamycin and its Derivatives) and Nitrogen Containing Bisphosphonates: Bi-Functional Compounds for the Treatment of Bone Tumours
|
Current Medicinal Chemistry
|
Benjamin Ory; Gatien Moriceau; Françoise Rédini; Dominique Heymann
|
10.2174/092986707780831159
|
26
|
212 |
Retinal degenerations: from cell signaling to cell therapy; pre-clinical and clinical issues.
|
Current Gene Therapy
|
Therese Cronin; Thierry Léveillard; José-Alain Sahel
|
10.2174/156652307780363143
|
29
|
213 |
Recent developments in tumor angiogenesis.
|
Current Pharmaceutical Biotechnology
|
Witold W. Kilarski; Andreas Bikfalvi
|
10.2174/138920107779941444
|
16
|
214 |
Interest of α2-Adrenergic Agonists and Antagonists in Clinical Practice: Background, Facts and Perspectives
|
Current Topics In Medicinal Chemistry
|
Pierre-Antoine Crassous; Colette Denis; Hervé Paris; Jean-Michel Senard
|
10.2174/156802607779318190
|
55
|
215 |
Neoangiogenesis induced by progenitor endothelial cells: effect of fucoidan from marine algae.
|
Cardiovascular & Hematological Agents In Medicinal Chemistry
|
Catherine Boisson-Vidal; Faouzia Zemani; G. Caligiuri; Isabelle Galy-Fauroux; Sylvia Colliec-Jouault; D. Helley; Anne-Marie Fischer
|
10.2174/187152507779315778
|
36
|
216 |
Genetic variation of human adrenergic receptors: from molecular and functional properties to clinical and pharmacogenetic implications.
|
Current Topics In Medicinal Chemistry
|
Stéphane Schaak; Jeanne Mialet-Perez; Christodoulos S. Flordellis; Hervé Paris
|
10.2174/156802607779318163
|
19
|
217 |
Voltage-gated sodium channels: new targets in cancer therapy?
|
Current Pharmaceutical Design
|
Sébastien Roger; Marie Potier; Christophe Vandier; Pierre Besson; Jean-Yves Le Guennec
|
10.2174/138161206778522047
|
68
|
218 |
Electrotransfer into skeletal muscle for protein expression.
|
Current Gene Therapy
|
Capucine Trollet; Carole Bloquel; Daniel Scherman; Pascal Bigey
|
10.2174/156652306778520656
|
64
|
219 |
Receptor-Based Computational Screening of Compound Databases: The Main Docking-Scoring Engines
|
Current Protein & Peptide Science
|
Olivier Sperandio; Maria A. Miteva; François Delfaud; Bruno O. Villoutreix
|
10.2174/138920306778559377
|
48
|
220 |
Hypersensitivity Reactions to Iodinated Contrast Media
|
Current Pharmaceutical Design
|
Rosa-Maria Guéant-Rodriguez; Antonino Romano; Annick Barbaud; Knut Brockow; Jean-Louis Guéant
|
10.2174/138161206778193999
|
43
|
221 |
IgE-Mediated Hypersensitivity to Cephalosporins
|
Current Pharmaceutical Design
|
Jean-Louis Guéant; Rosa-Maria Guéant-Rodriguez; Marinella Viola; Rocco Luigi Valluzzi; Antonino Romano
|
10.2174/138161206778194060
|
29
|
222 |
Drug hypersensitivity: epidemiology and risk factors.
|
Current Pharmaceutical Design
|
Laurence Guglielmi; P. Guglielmi; Pascal Demoly
|
10.2174/138161206778194088
|
23
|
223 |
Kinins and cardiovascular diseases.
|
Current Pharmaceutical Design
|
Jin Bo Su
|
10.2174/138161206778194051
|
27
|
224 |
Role of ABC transporters in the chemoresistance of human gliomas.
|
Current Cancer Drug Targets
|
Xavier Declèves; Alexandra Benouaich Amiel; Jean-Yves Delattre; Jean-Michel Scherrmann
|
10.2174/156800906777723930
|
56
|
225 |
Diagnostics, prognostic and therapeutic exploitation of telomeres and telomerase in leukemias.
|
Current Pharmaceutical Biotechnology
|
Laure Deville; Josette Hillion; Michel Lanotte; Philippe Rousselot; Evelyne Ségal-Bendirdjian
|
10.2174/138920106777549768
|
13
|
226 |
Ligand binding domain of vitamin D receptors.
|
Current Topics In Medicinal Chemistry
|
Natacha Rochel; Dino Moras
|
10.2174/156802606777864926
|
34
|
227 |
Development, validation, and applications of anisotropic polarizable molecular mechanics to study ligand and drug-receptor interactions.
|
Current Pharmaceutical Design
|
Nohad Gresh
|
10.2174/138161206777585256
|
24
|
228 |
Ultrasonic Elasticity Imaging as a Tool for Breast Cancer Diagnosis and Research
|
Current Medical Imaging Reviews
|
C. Pellot-Barakat; Mallika Sridhar; Karen K. Lindfors; Michael F. Insana
|
10.2174/157340506775541631
|
29
|
229 |
The dopamine D3 receptor: a therapeutic target for the treatment of neuropsychiatric disorders.
|
CNS & Neurological Disorders Drug Targets
|
Ludovic Leriche; Erwan Bezard; C.E. Gross; Olivier Guillin; Bernard Le Foll; Jorge Diaz; Pierre Sokoloff
|
10.2174/187152706784111551
|
277
|
230 |
Matrix metalloproteinases: a potential therapeutic target in atherosclerosis.
|
Current Drug Targets. Cardiovascular & Haematological Disorders
|
Mustapha Rouis
|
10.2174/156800605774961979
|
24
|
231 |
Prospects for the Resistance to HIV Protease Inhibitors: Current Drug Design Approaches and Perspectives
|
Current Pharmaceutical Design
|
Stéphane Burlet; Nicolas Pietrancosta; Younes Laras; Cédrik Garino; Gilles Quéléver; Jean-Louis Kraus
|
10.2174/1381612054864939
|
9
|
232 |
The Key Role of Medullary 5-HT3 Receptors in the Serotonin-Mediated Neural Control of Cardiovascular Function.
|
Current Neuropharmacology
|
Caroline Sévoz-Couche; B. H. Machado; Martial Hamon; Raul Laguzzi
|
10.2174/1570159054368277
|
1
|
233 |
Hepcidin in iron metabolism.
|
Current Protein & Peptide Science
|
Olivier Loréal; Christelle Haziza-Pigeon; Marie-Bérengère Troadec; Lénaïck Détivaud; Bruno Turlin; Brice Courselaud; Guennadi Ilyin; Pierre Brissot
|
10.2174/1389203054065392
|
47
|
234 |
Helper functions required for wild type and recombinant adeno-associated virus growth.
|
Current Gene Therapy
|
Marie-Claude Geoffroy; Anna Salvetti
|
10.2174/1566523054064977
|
58
|
235 |
Chemokines and brain functions.
|
Current Drug Targets. Inflammation And Allergy
|
Ghazal Banisadr; William Rostène; Patrick Kitabgi; Stéphane Melik Parsadaniantz
|
10.2174/1568010054022097
|
78
|
236 |
Integrin function and signaling as pharmacological targets in cardiovascular diseases and in cancer.
|
Current Pharmaceutical Design
|
E. Paulhe; Stéphane Manenti; Loic Ysebaert; R. Betous; P. Sultan; Claire Racaud-Sultan
|
10.2174/1381612054065765
|
16
|
237 |
Voltage Gated Calcium Channels as Targets for Analgesics
|
Current Topics In Medicinal Chemistry
|
Emmanuel Bourinet; Gerald W. Zamponi
|
10.2174/1568026054367610
|
39
|
238 |
Combining polymeric devices and stem cells for the treatment of neurological disorders: a promising therapeutic approach.
|
Current Drug Targets
|
V. M. Tatard; Philippe Menei; Jean-Pierre Benoit; Claudia N. Montero-Menei
|
10.2174/1389450053344885
|
33
|
239 |
Chemoresistance in non-small cell lung cancer.
|
Current Medicinal Chemistry. Anti-cancer Agents
|
Pascal Sève; Charles Dumontet
|
10.2174/1568011053352604
|
124
|
240 |
Cellular and Molecular Effects of Macrolides on Leukocyte Function
|
Current Pharmaceutical Design
|
Marie-Thérèse Labro
|
10.2174/1381612043383403
|
27
|
241 |
Neprilysin 2: a novel messenger peptide-inactivating metalloprotease.
|
Protein And Peptide Letters
|
Tanja Ouimet
|
10.2174/0929866043406625
|
4
|
242 |
Tumor cell resistance to DNA-damaging agents: from apoptosis to neiosis.
|
Current Medicinal Chemistry. Anti-cancer Agents
|
François Martin; Eric Solary
|
10.2174/1568011043352768
|
8
|
243 |
Cancer gene therapy through autonomous parvovirus--mediated gene transfer.
|
Current Gene Therapy
|
Jan Cornelis; Susanne I. Lang; Alexandra Stroh-Dege; Ginette Balboni; Christiane Dinsart; Jean Rommelaere
|
10.2174/1566523043346228
|
33
|
244 |
Growth Factors and Bone Formation in Osteoporosis: Roles for Fibroblast Growth Factor and Transforming Growth Factor Beta
|
Current Pharmaceutical Design
|
Olivia Fromigué; Dominique Modrowski; Pierre J. Marie
|
10.2174/1381612043383773
|
50
|
245 |
Lamellarins, from A to Z: a family of anticancer marine pyrrole alkaloids.
|
Current Medicinal Chemistry. Anti-cancer Agents
|
Christian Bailly
|
10.2174/1568011043352939
|
172
|
246 |
Design of novel antitumor DNA alkylating agents: the benzacronycine series.
|
Current Medicinal Chemistry. Anti-cancer Agents
|
Marie-Hélène David-Cordonnier; William Laine; Thomas Gaslonde; Sylvie Michel; François Tillequin; Michel H. J. Koch; Stéphane Léonce; Alain Pierre; Christian Bailly
|
10.2174/1568011043482115
|
14
|
247 |
5-HT1 receptors.
|
Current Drug Targets. CNS And Neurological Disorders
|
Laurence Lanfumey; Michel Hamon
|
10.2174/1568007043482570
|
135
|
248 |
5-HT4 receptors.
|
Current Drug Targets. CNS And Neurological Disorders
|
Joël Bockaert; Sylvie Claeysen; Valérie Compan; Aline Dumuis
|
10.2174/1568007043482615
|
167
|
249 |
Animal models of HLA-B27-associated diseases.
|
Current Molecular Medicine
|
Maxime Breban; Cécile Hacquard-Bouder; Géraldine Falgarone
|
10.2174/1566524043479347
|
48
|
250 |
Revisiting Pitfalls, Problems and Tentative Solutions for Assaying [General Articles] Mitochondrial Respiratory Chain Complex III in Human Samples
|
Current Medicinal Chemistry
|
Dominique Chretien; Abdelhamid Slama; Jean-Jacques Brière; Arnold Munnich; Agnès Rötig; Pierre Rustin
|
10.2174/0929867043456151
|
27
|
251 |
Thirty years of polyamine-related approaches to cancer therapy. Retrospect and prospect. Part 2. Structural analogues and derivatives.
|
Current Drug Targets
|
Nikolaus Seiler
|
10.2174/1389450033490876
|
97
|
252 |
Thirty Years of Polyamine-Related Approaches to Cancer Therapy. Retrospect and Prospect. Part 1. Selective Enzyme Inhibitors
|
Current Drug Targets
|
Nikolaus Seiler
|
10.2174/1389450033490885
|
151
|
253 |
New antiviral nucleoside prodrugs await application.
|
Current Medicinal Chemistry
|
Carole Anastasi; Gilles Quéléver; Stéphane Burlet; Cédrik Garino; Florence Souard; Jean-Louis Kraus
|
10.2174/0929867033457034
|
28
|
254 |
Drug resistance to cytotoxic nucleoside analogues.
|
Current Drug Targets
|
Lars Petter Jordheim; Carlos M. Galmarini; Charles Dumontet
|
10.2174/1389450033490957
|
34
|
255 |
Bcl-2 proteins: targets and tools for chemosensitisation of tumor cells.
|
Current Medicinal Chemistry. Anti-cancer Agents
|
Ali Bettaieb; Laurence Dubrez-Daloz; Sophie Launay; Stéphanie Plenchette; Cédric Rébé; Séverine Cathelin; Eric Solary
|
10.2174/1568011033482396
|
32
|
256 |
Gab1, SHP-2 and Other Novel Regulators of Ras: Targets for Anticancer Drug Discovery?
|
Current Cancer Drug Targets
|
Armelle Yart; Patrick Mayeux; Patrick Raynal
|
10.2174/1568009033481976
|
26
|
257 |
Gene therapy of chronic pain.
|
Current Gene Therapy
|
Michel Pohl; Alice Meunier; Michel Hamon; Joao M. Braz
|
10.2174/1566523034578348
|
26
|
258 |
Vascular endothelial cell growth factor (VEGF), an emerging target for cancer chemotherapy.
|
Current Medicinal Chemistry. Anti-cancer Agents
|
S Shinkaruk; M. Bayle; G. Lain; Gérard Déléris
|
10.2174/1568011033353452
|
182
|
259 |
Nucleic acids as targets for antitelomerase agents.
|
Mini Reviews In Medicinal Chemistry
|
Patrizia Alberti; Laurent Lacroix; Lionel Guittat; Claude Hélène; Jean-Louis Mergny
|
10.2174/1389557033405485
|
22
|
260 |
Retinoic acid metabolism and mechanism of action: a review.
|
Current Drug Metabolism
|
Julie Marill; Nadia Idres; Claude Capron; Eric Nguyen; Guy G. Chabot
|
10.2174/1389200033336900
|
184
|
261 |
In vitro and in vivo antitumor effects of bisphosphonates.
|
Current Medicinal Chemistry
|
Philippe Clézardin; Pierrick G.J. Fournier; Sandrine Boissier; Olivier Peyruchaud
|
10.2174/0929867033368529
|
73
|
262 |
Dendritic cells in innate immune responses against HIV.
|
Current Molecular Medicine
|
C. Servet; Laurence Zitvogel; Anne Hosmalin
|
10.2174/1566524023361907
|
54
|
263 |
Unusual DNA conformations: implications for telomeres.
|
Current Medicinal Chemistry. Anti-cancer Agents
|
Martin Mills; Laurent Lacroix; Paola B. Arimondo; Jean-Louis Leroy; Jean-Christophe François; Horst H. Klump; Jean-Louis Mergny
|
10.2174/1568011023353877
|
44
|
264 |
Heterotrimeric G proteins control diverse pathways of transmembrane signaling, a base for drug discovery.
|
Mini Reviews In Medicinal Chemistry
|
Yves Landry; J.-P. Gies
|
10.2174/1389557023405945
|
28
|
265 |
Labelled oligonucleotides as radiopharmaceuticals: pitfalls, problems and perspectives.
|
Current Pharmaceutical Design
|
Cheraz Khelifi Younes; Raphaël Boisgard; Bertrand Tavitian
|
10.2174/1381612023394467
|
68
|
266 |
Structural bioinformatics: methods, concepts and applications to blood coagulation proteins.
|
Current Protein & Peptide Science
|
Bruno O. Villoutreix
|
10.2174/1389203023380657
|
15
|
267 |
Driving in vitro selection of anti-HIV-1 TAR aptamers by magnesium concentration and temperature.
|
Combinatorial Chemistry & High Throughput Screening
|
Fabien Darfeuille; D. Sekkai; Eric Dausse; Gaëlle Kolb; L. Yurchenko; Claudine Boiziau; Jean-Jacques Toulmé
|
10.2174/1386207023330282
|
12
|
268 |
Leech thrombin inhibitors.
|
Current Pharmaceutical Design
|
Michel Salzet
|
10.2174/1381612023395664
|
45
|
269 |
Genetic engineering in allotransplantation of vascularized organs.
|
Current Gene Therapy
|
Patrick Mathieu; Christine Chauveau; D Bouchet; C. Guillot; Laurent Tesson; Ignacio Anegon
|
10.2174/1566523023348147
|
5
|
270 |
Progress in Gene Delivery by Cationic Lipids : Guanidinium-Cholesterol-Based Systems as an Example
|
Current Drug Targets
|
Abderrahim Aissaoui; Noufissa Oudrhiri; Laure Petit; Michelle Hauchecorne; Erwan Kan; Matthieu Sainlos; Sebastien Julia; Jean Navarro; Jean-Pierre Vigneron; Jean-Marie Lehn
|
10.2174/1389450023348082
|
49
|
271 |
Design of new anti-cancer agents based on topoisomerase poisons targeted to specific DNA sequences.
|
Current Medicinal Chemistry. Anti-cancer Agents
|
Paola B. Arimondo; Hélène C
|
10.2174/1568011013354642
|
17
|
272 |
Molecular basis for designing selective modulators of retinoic acid receptor transcriptional activities.
|
Current Drug Targets. Immune, Endocrine And Metabolic Disorders
|
P. Lefebvre
|
10.2174/1568008013341389; 10.2174/1568005310101020153
|
27
|
273 |
Chemokine receptors as anti-retroviral targets.
|
Current Drug Targets
|
Nicolaus Heveker
|
10.2174/1389450013348849
|
9
|
274 |
Dosimetry and Microdosimetry of Targeted Radiotherapy
|
Current Pharmaceutical Design
|
Manuel Bardiès; Pascal Pihet
|
10.2174/1381612003399176
|
29
|
275 |
Ornithine aminotransferase, a potential target for the treatment of hyperammonemias.
|
Current Drug Targets
|
Nikolaus Seiler
|
10.2174/1389450003349254
|
39
|
276 |
Design and Evaluation of Hepatitis B Virus Inhibitors
|
Current Pharmaceutical Design
|
Olivier Hantz; Jean-Louis Kraus; Fabien Zoulim
|
10.2174/1381612003400740
|
6
|
277 |
Topoisomerase I Poisons and Suppressors as Anticancer Drugs
|
Current Medicinal Chemistry
|
Christian Bailly
|
10.2174/0929867003375489
|
216
|